Search research articles
Contact Us
Filters
Showing results (191-200 of 205) with videos related to
Page
of 21
Sort By:
The New England Journal of Medicine
|
September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
Neil D Gross, David M Miller, Nikhil I Khushalani, et al.
Pigment Cell & Melanoma Research
|
October 7, 2023
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)
Alexander Z Wei, Lanyi N Chen, Marlana Orloff, et al.
Journal for Immunotherapy of Cancer
|
June 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma
James William Smithy, Allison Betof, Sebastian Klobuch, et al.
Journal for Immunotherapy of Cancer
|
January 20, 2025
Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade
Stephanie L Alden, Soren Charmsaz, Howard L Li, et al.
Cancer Immunology Research
|
January 11, 2022
Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
Maryam Pourmaleki, Caitlin J Jones, Charlotte E Ariyan, et al.
Cancer Research Communications
|
September 15, 2025
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy
Howard L Li, Soren Charmsaz, Mari Nakazawa, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
International real-world study of combination immunotherapy sequences in metastatic melanoma
Mora Guardamagna, Sarah E Lochrin, James William Smithy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2019
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Paul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
The New England Journal of Medicine
|
April 20, 2016
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Science (New York, N.Y.)
|
June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 205) with videos related to
Sort By:
Page
of 21
The New England Journal of Medicine
|
September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
Neil D Gross, David M Miller, Nikhil I Khushalani, et al.
Pigment Cell & Melanoma Research
|
October 7, 2023
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)
Alexander Z Wei, Lanyi N Chen, Marlana Orloff, et al.
Journal for Immunotherapy of Cancer
|
June 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma
James William Smithy, Allison Betof, Sebastian Klobuch, et al.
Journal for Immunotherapy of Cancer
|
January 20, 2025
Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade
Stephanie L Alden, Soren Charmsaz, Howard L Li, et al.
Cancer Immunology Research
|
January 11, 2022
Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
Maryam Pourmaleki, Caitlin J Jones, Charlotte E Ariyan, et al.
Cancer Research Communications
|
September 15, 2025
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy
Howard L Li, Soren Charmsaz, Mari Nakazawa, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
International real-world study of combination immunotherapy sequences in metastatic melanoma
Mora Guardamagna, Sarah E Lochrin, James William Smithy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2019
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Paul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
The New England Journal of Medicine
|
April 20, 2016
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Science (New York, N.Y.)
|
June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
Page
of 21